These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 604117)

  • 21. Temperature-sensitive mutants of influenza virus. XIII. Evaluation of influenza A/Hong Kong/68 and A/Udorn/72 ts and wild-type viruses in tracheal organ culture at permissive and restrictive temperatures.
    Mostow SR; Flatauer S; Paler M; Murphy BR
    J Infect Dis; 1977 Jul; 136(1):1-6. PubMed ID: 886200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live cold-adapted influenza A vaccine produced in Vero cell line.
    Romanova J; Katinger D; Ferko B; Vcelar B; Sereinig S; Kuznetsov O; Stukova M; Erofeeva M; Kiselev O; Katinger H; Egorov A
    Virus Res; 2004 Jul; 103(1-2):187-93. PubMed ID: 15163508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI; Furminger IG
    Dev Biol Stand; 1975; 28():167-72. PubMed ID: 1126566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of resistance to influenza virus infection in animal models.
    Potter CW; McLaren C; Jennings R
    Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of live attenuated influenza vaccine ts-1(E) in man.
    Gwaltney JM
    Dev Biol Stand; 1976; 33():178-83. PubMed ID: 782966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection afforded by intranasal immunization with the neuraminidase-lacking mutant of influenza A virus in a ferret model.
    Mishin VP; Nedyalkova MS; Hayden FG; Gubareva LV
    Vaccine; 2005 Apr; 23(22):2922-7. PubMed ID: 15780741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Criteria in the evaluation of live intranasal influenza virus vaccines.
    Zygraich N
    Dev Biol Stand; 1976; 33():141-50. PubMed ID: 782962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Live attenuated influenza vaccines in young seronegative children.
    Wright PF; Kervina M; Thompson J; Torrence AE; Karzon DT
    Dev Biol Stand; 1977 Jun 1-3; 39():99-103. PubMed ID: 604140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza.
    Sabin AB
    Dev Biol Stand; 1976; 33():127-40. PubMed ID: 955265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate.
    Wressnigg N; Voss D; Wolff T; Romanova J; Ruthsatz T; Mayerhofer I; Reiter M; Nakowitsch S; Humer J; Morokutti A; Muster T; Egorov A; Kittel C
    Vaccine; 2009 May; 27(21):2851-7. PubMed ID: 19366569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of attenuated influenza viruses.
    Beare AS; Maassab HF; Tyrrell DA; Slepuskin AN; Hall TS
    Bull World Health Organ; 1971; 44(5):593-8. PubMed ID: 5316742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo and in vitro hamster models in the assessment of virulence of recombinant influenza viruses.
    Heath AW; Addison C; Ali M; Teale D; Potter CW
    Antiviral Res; 1983 Nov; 3(4):241-52. PubMed ID: 6667018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on live influenza virus vaccine. I. Attenuated influenza A2 Hong Kong virus and its biological and immunological characteristics (author's transl)].
    Izuchi T; Mizutani H
    Uirusu; 1973 Jun; 23(2):134-40. PubMed ID: 4808069
    [No Abstract]   [Full Text] [Related]  

  • 36. [Neuraminidase activity of inactivated influenza vaccines].
    Buchowicz I; Wrzos H; Filczak K; Bańkowski A; Korbecki M
    Med Dosw Mikrobiol; 1979; 31(2):103-10. PubMed ID: 502643
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of sevral wild-type influenza viruses in the ferret tracheal organ culture system.
    Hoke CH; Hopkins JA; Meiklejohn G; Mostow SR
    Rev Infect Dis; 1979; 1(6):946-54. PubMed ID: 399387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Optimal temperature of enzyme activity and heat resistance of neuraminidases as attenuation markers for influenza viruses].
    Profeta ML; Ferrante P; Kotseva R
    Boll Ist Sieroter Milan; 1977 Nov; 56(5):410-7. PubMed ID: 597391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavior of vaccine revertants of temperature-sensitive mutants of influenza virus in ferret tracheal organ culture.
    Mostow SR; Hopkins JA; Wright PF
    Infect Immun; 1979 Oct; 26(1):193-6. PubMed ID: 500202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The behaviour in vitro of attenuated recombinant influenza viruses.
    Mostow SR; Tyrrell DA
    Arch Gesamte Virusforsch; 1973; 43(4):385-92. PubMed ID: 4799157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.